Bioqual, Inc.
BIOQ · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $48,868 | $58,591 | $62,664 | $66,150 |
| % Growth | -16.6% | -6.5% | -5.3% | – |
| Cost of Goods Sold | $50,764 | $51,162 | $50,059 | $53,145 |
| Gross Profit | -$1,896 | $7,429 | $12,605 | $13,005 |
| % Margin | -3.9% | 12.7% | 20.1% | 19.7% |
| R&D Expenses | $0 | $0 | $806 | $1,115 |
| G&A Expenses | $0 | $0 | $7,542 | $6,472 |
| SG&A Expenses | $0 | $7,449 | $11,502 | $5,357 |
| Sales & Mktg Exp. | $0 | $0 | $3,960 | -$1,115 |
| Other Operating Expenses | $6,320 | $0 | -$808 | $0 |
| Operating Expenses | $6,320 | $7,449 | $11,500 | $6,472 |
| Operating Income | -$1,896 | -$20 | $1,103 | $6,533 |
| % Margin | -3.9% | -0% | 1.8% | 9.9% |
| Other Income/Exp. Net | $609 | $496 | $30 | $44 |
| Pre-Tax Income | -$1,287 | $476 | $1,133 | $6,577 |
| Tax Expense | -$238 | -$7 | $298 | $1,316 |
| Net Income | -$1,048 | $483 | $836 | $5,261 |
| % Margin | -2.1% | 0.8% | 1.3% | 8% |
| EPS | -1.17 | 0.54 | 0.93 | 5.88 |
| % Growth | -316.7% | -41.9% | -84.2% | – |
| EPS Diluted | -1.17 | 0.54 | 0.93 | 5.88 |
| Weighted Avg Shares Out | 894 | 895 | 898 | 894 |
| Weighted Avg Shares Out Dil | 894 | 894 | 894 | 894 |
| Supplemental Information | – | – | – | – |
| Interest Income | $609 | $476 | $28 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,406 | $2,556 | $5,834 | $8,185 |
| EBITDA | $510 | $3,032 | $6,968 | $14,762 |
| % Margin | 1% | 5.2% | 11.1% | 22.3% |